Pharmacist's perspective on HCQ treatment of COVID-19.
Identifieur interne : 001417 ( Main/Corpus ); précédent : 001416; suivant : 001418Pharmacist's perspective on HCQ treatment of COVID-19.
Auteurs : Ya-Ling Wang ; Shih-Han Wang ; Ai-Yu YangSource :
- The Kaohsiung journal of medical sciences [ 2410-8650 ] ; 2020.
English descriptors
- KwdEn :
- MESH :
- chemical : Azithromycin, Hydroxychloroquine.
- drug therapy : Coronavirus Infections.
- Betacoronavirus, COVID-19, Humans, Pandemics, Pharmacists, Pneumonia, Viral, SARS-CoV-2.
DOI: 10.1002/kjm2.12249
PubMed: 32533592
PubMed Central: PMC7323069
Links to Exploration step
pubmed:32533592Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pharmacist's perspective on HCQ treatment of COVID-19.</title>
<author><name sortKey="Wang, Ya Ling" sort="Wang, Ya Ling" uniqKey="Wang Y" first="Ya-Ling" last="Wang">Ya-Ling Wang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Shih Han" sort="Wang, Shih Han" uniqKey="Wang S" first="Shih-Han" last="Wang">Shih-Han Wang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yang, Ai Yu" sort="Yang, Ai Yu" uniqKey="Yang A" first="Ai-Yu" last="Yang">Ai-Yu Yang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32533592</idno>
<idno type="pmid">32533592</idno>
<idno type="doi">10.1002/kjm2.12249</idno>
<idno type="pmc">PMC7323069</idno>
<idno type="wicri:Area/Main/Corpus">001417</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001417</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Pharmacist's perspective on HCQ treatment of COVID-19.</title>
<author><name sortKey="Wang, Ya Ling" sort="Wang, Ya Ling" uniqKey="Wang Y" first="Ya-Ling" last="Wang">Ya-Ling Wang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Shih Han" sort="Wang, Shih Han" uniqKey="Wang S" first="Shih-Han" last="Wang">Shih-Han Wang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yang, Ai Yu" sort="Yang, Ai Yu" uniqKey="Yang A" first="Ai-Yu" last="Yang">Ai-Yu Yang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">The Kaohsiung journal of medical sciences</title>
<idno type="eISSN">2410-8650</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pharmacists (MeSH)</term>
<term>Pneumonia, Viral (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Azithromycin</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Pharmacists</term>
<term>Pneumonia, Viral</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32533592</PMID>
<DateCompleted><Year>2020</Year>
<Month>12</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2410-8650</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>36</Volume>
<Issue>8</Issue>
<PubDate><Year>2020</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>The Kaohsiung journal of medical sciences</Title>
<ISOAbbreviation>Kaohsiung J Med Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Pharmacist's perspective on HCQ treatment of COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>660</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/kjm2.12249</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Ya-Ling</ForeName>
<Initials>YL</Initials>
<Identifier Source="ORCID">0000-0001-9389-5234</Identifier>
<AffiliationInfo><Affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Shih-Han</ForeName>
<Initials>SH</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Ai-Yu</ForeName>
<Initials>AY</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>06</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>China (Republic : 1949- )</Country>
<MedlineTA>Kaohsiung J Med Sci</MedlineTA>
<NlmUniqueID>100960562</NlmUniqueID>
<ISSNLinking>1607-551X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Int J Antimicrob Agents. 2020 Jul;56(1):105949</RefSource>
<PMID Version="1">32205204</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="Y">Azithromycin</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010595" MajorTopicYN="Y">Pharmacists</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>05</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>6</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>6</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32533592</ArticleId>
<ArticleId IdType="doi">10.1002/kjm2.12249</ArticleId>
<ArticleId IdType="pmc">PMC7323069</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Mal Infect. 2020 Jun;50(4):384</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32240719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2411-2418</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32379955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Toxicol Appl Pharmacol. 1967 May;10(3):501-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6059665</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001417 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001417 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32533592 |texte= Pharmacist's perspective on HCQ treatment of COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32533592" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |